MetaCap

Rockwell Medical Inc. Company Profile

NASDAQ: RMTIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.89-0.13 (-1.62%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Rockwell Medical at a glance

Rockwell Medical Inc. (NASDAQ: RMTI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Wixom, MI. Rockwell Medical is led by Dr. Mark Strobeck Ph.D. and employs about 157 people. The company's shares have traded publicly since 1998.

At a market capitalization of $32.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001041024, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Rockwell Medical do?

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Business description based on the company's public filings.

Company information

Legal name
Rockwell Medical Inc.
Ticker
NASDAQ: RMTI
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Mark Strobeck Ph.D.
Employees
157
Headquarters
30142 South Wixom road, Wixom, MI, United States
Phone
248 960 9009
IPO year
1998
Market cap
$32.32M
SEC CIK
0001041024
Latest annual report
10-K · Mar 26, 2026

Companies similar to Rockwell Medical

RMTI peer companies
CompanyPrice% ChgMarket capCompare
NXTCNextCure Inc.7.18+5.90%$32.87Mvs RMTI
RNAZTransCode Therapeutics Inc.1.86+8.77%$31.49Mvs RMTI
NNVCNanoViricides Inc.1.30-0.76%$33.18Mvs RMTI
MIRAMIRA Pharmaceuticals Inc.0.7455+6.05%$31.33Mvs RMTI
BCTXBriaCell Therapeutics Corp.3.91-0.13%$34.02Mvs RMTI
ATNMActinium Pharmaceuticals Inc. (Delaware)1.10+1.85%$34.59Mvs RMTI
GRDXGridAI Technologies Corp.4.97+3.54%$35.44Mvs RMTI
IGCIGC Pharma Inc.0.2799-1.75%$28.94Mvs RMTI

Related